HBI 2016 Sponsors

Healthcare Business International 2016 brings together investors and big health care service operators from across Europe and Emerging Markets to understand markets, business models and sectors. It is the only event to offer a global overview coupled to deep insight into the private healthcare services sector.

HBI Sponsors have the opportunity to meet influencers, leaders and innovators from across the industry and associate themselves with "Big Health Care Services" a fast-growing global business.

To find out how your organisation can become an HBI 2016 Sponsor please contact us at Tel: + 44 (0) 20 7183 3779 or email: amanda@healthcareeuropa.com

Strategic sponsors

Abbott Diagnostics

Abbott Diagnostics is a global leader in in vitro diagnostics offering a broad portfolio spanning immunoassay, clinical chemistry, hematology, blood screening, molecular, bio-identification, point-of-care, informatics and professional services. Our diagnostics solutions are more than just a test or data point – working together across our business units and more than 22,000 customers in more such a broad portfolio, Abbott is focused on an integrated diagnostics solution—powered by innovations that can help our customers channel change into growth and ensure exceptional performance.

Visit Abbott Diagnostics at www.abbottdiagnostics.com

GE Healthcare

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

Visit GE Healthcare at www.ge.com

International Finance Corporation - IFC

IFC, a member of the World Bank Group, is the world’s largest multilateral investor in private healthcare, managing an active portfolio of about $1.3 billion worth of health investments. IFC investments in service providers, pharmaceuticals and medical technology are aimed at promoting greater access to affordable, high-quality healthcare. With our local presence in over 100 offices worldwide, we use our capital, expertise and influence to create opportunity where it is needed most.

Visit International Finance Corporation at www.ifc.org

Medical Properties Trust

Medical Properties Trust, Inc. bridges the gap between the growing demand for high-quality healthcare and the ability to deliver it cost-effectively. Specializing in acute care, community and rehabilitation hospitals, this healthcare real estate investment trust (REIT) provides operators access to capital for facility improvements, technology upgrades, staff additions and new construction through long-term net leases of real estate assets. By reinvesting non-earning assets into operations, MPT clients are able to participate in the growth of the largest sector of the U.S. and a growing sector of other developed economies.

For more information, visit www.medicalpropertiestrust.com


Siemens Healthcare is one of the world’s largest suppliers of medical infrastructure and is a leader in medical imaging, laboratory diagnostics, and clinical IT. Siemens Healthcare aspires to become the trusted partner of healthcare providers worldwide – the partner that they can rely on to help drive their clinical excellence, operational efficiency, and profitability.

With around 43,000 employees worldwide and a presence throughout the world, Siemens Healthcare generated revenue worth 11.7 billion euros and profits of more than 2 billion euros in fiscal 2014.

Source: www.healthcare.siemens.com/healthcare-company-profile

Event sponsors

Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in more than 300 private equity transactions in 40 countries and, as of December 31, 2015 has €27 billion in assets under management. With offices on four continents, Advent has established a globally integrated team of over 170 investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecom. After more than 30 years dedicated to international investing, Advent remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit www.adventinternational.co.uk

Knight Frank

Knight Frank LLP is the world’s largest and leading independent global residential and commercial property consultancy. Today it is widely regarded throughout the world as the firm of choice for high quality commercial and residential property operating in key hubs across the globe.

Knight Frank’s Healthcare Department, the sector’s leading property consultant, annually advises on in excess of £8BN of assets throughout Europe.

In 2015 the team advised on almost £6.5BN and transacted on £500m of healthcare assets. Furthermore, they have advised on almost £1.5BN of USREIT transactions in to the UK.

Visit Knight Frank at www.knightfrank.co.uk/commercial/healthcare



UBS is committed to providing wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland, with superior financial advice and solutions while generating attractive and sustainable returns for shareholders. Its strategy centers on its Wealth Management and Wealth Management Americas businesses and its leading universal bank in Switzerland, complemented by its Asset Management business and its Investment Bank. These businesses share three key characteristics: they benefit from a strong competitive position in their targeted markets, are capital-efficient, and offer a superior structural growth and profitability outlook. UBS's strategy builds on the strengths of all of its businesses and focuses its efforts on areas in which it excels, while seeking to capitalize on the compelling growth prospects in the businesses and regions in which it operates. Capital strength is the foundation of its success.

Headquartered in Zurich, Switzerland, UBS has offices in more than 50 countries, including all major financial centers, and approximately 60,000 employees. UBS Group AG is the holding company of the UBS Group. Under Swiss company law, UBS Group AG is organized as an Aktiengesellschaft, a corporation that has issued shares of common stock to investors. The operational structure of the Group comprises the Corporate Center and five business divisions: Wealth Management, Wealth Management Americas, Personal & Corporate Banking, Asset Management and the Investment Bank.

Visit UBS at www.ubs.com
Operator CEOs present and discuss the growth opportunities in acute care. How are large hospital groups outsourcing, partnering with public payors and building new opportunities in private pay? How far will new channels increase patient flow?

Confirmed speakers include Benoit Chastaing, Head of Strategy and Development, MediPole Partenaires, the second largest French hospital group on recent consolidation. Elmar Willebrand, CEO, Accumeda, the fast-growing German hospital chain who has done over 100 acquisitions, first at Asklepios, and, since 2008, at Accumeda, Mark Page, CEO, Ramsay Health Care UK and Wolfgang Hofmann, SVP, Head of Integrated Care, Fresenius Medical Care.

The French hospital sector - Opportunities and Threats Benoit Chastaing, Head of Strategy and Development, MediPole Partenaires Benoit helped engineer the merger of Medipartenaires and Medipole to create the second largest French hospital chain with sales of €1.3bn. What does this extra scale mean for the group operationally and in terms of influence with payors? Benoit looks at the prospects for a sector which has seen tariff reductions. What are the oportunities and growth prospects?
Opportunities in German acute healthcare Elmar H. Willebrand, CEO, Accumeda Elmar H. Willebrand has done over 100 successful acquisitions in the German acute and rehabilitation care sector, first for 14 years at Asklepios, where he master-minded the privatisation of half Hamburg's hospitals with sales of €750m, and, since 2008, at Accumeda, which he has built to neary €90m. Is privatization still an option in Germany? What opportunities are in the pipeline? Is there a switch to ambulatory treatment or in investing in primary and specialist outpatient centres? What will the German sector look like in ten years time?
FMC: expanding international specialized healthcare beyond Dialysis Wolfgang Hofmann, SVP, Head of Integrated Care, Fresenius Medical Care The world's largest dialysis group, Fresenius Medical Care, has outlined plans which should see it make significant healthcare service acquisitions in the next years. These will take it well beyond dialysis and into carefully selected new sub-sectors. Here Wolfgang presents on how FMC sees the sector in Europe and beyond. How does he expect the sector to evolve, what makes it so attractive?
Confirmed speakers include Christian Mayer, CEO, Vivaneo, which runs IVF clinics across Germany, the Netherlands and Denmark.

Managing Fluctuations in demand for Ambulatory Care Fredrik Ragmark, CEO, Medicover Near immediate access to a doctor is often THE unique selling point for private healthcare. But delivering that, through the peaks and troughs of demand trigged by such things as the flu season, isn’t easy. Ragmark looks at how Medicover uses predictive modelling and flexible contracts to meet patient needs.
Business models in outpatient care in SE Asia Karim Dhala, Executive Director, Qualitas Qualitas runs an outpatient network across Malaysia and Singapore with operations also in India and Australia. Here Dhala looks at how the outpatient market is growing, profiles typical customers and gives his views on the future as well as the Qualitas Business Model.
The IVF market in Europe and how it is changing Christian Mayer, CEO, Vivaneo With a footprint in Germany, the Netherlands and Denmark, Vivaneo is one of the few international players in fertility in Europe. Here Christian looks at the sector and how it is changing. What are its growth prospects?
Revolutionising rehabilitation from acute to ehealth Dr André Schmidt, CEO, Median Created from the merger of Median and RHM, Median is now the largest rehabilitation group in Germany with 2015 sales of €700m. It now plans to build a network that offers almost all Germans easy access to “joined-up” rehabilitation with clinically-proven results. André looks at how the group plans to create patient pathways that provide care continuum from acute through to residential rehabilitation, outpatient care in big cities and on to ehealth.
Lab and imaging are at the core of successful healthcare. Here CEOs look at new models such as wellness and B2C, at how far rationalisation can reduce costs as tariffs fall and the likely impact of new distribution models.

The European lab sector - Opportunities and Threats Hedley Goldberg, Managing Director, Rothschild As an adviser, Rothschild has been intimately involved in the recent restructuring of the lab sector in Europe. So who better than Hedley to give a detailed overview of the sector today and to analyse how it is set to change over the next decade?
Making the lab industry fit for the future Michiel Boehmer, COO, Unilabs Michiel looks at the turnaround at international lab group Unilabs, which has seen very strong top and bottom line performance. In particular, he looks at how he applied applied the best practice in industrial manufacturing he learnt navigating Dutch giant Aalbers Industries through the recession. He shares how thinking differently can truly make a difference.
Success strategies for the next decade Chris Fourie, Partner, LTS Consulting How will Information and technology enable lab groups to build a competitive edge? In this wide-ranging presentation, LTS looks at how much mileage remains in automation, before analysing other differentiators, such as quality, agility, proactivity and interfaces with doctors, patients and payors. LTS has been helping lab groups in Europe, Africa and South America for over a decade and brings a wealth of expertise on how labs are addressing challenges in a fast changing market.
This is followed by a panel of lab operators. They include Dr David Atkins, CEO, Synevo, the Pan-East European lab group, Dr Charles Woler, CEO of Eurofins Biologie Spécilisée which is the holding company for big French reference lab Biomnis (part of listed international lab group Eurofins) and Marc Bouvier-Berthet, CEO of French lab group Biomed34. Issues covered include outsourcing, cost reduction, genetic tests and tariffs.
Demographics favour a huge expansion in demand in this sector. But public payors are increasingly switching away from residential options. Here the CEOs of operators explore opportunities such as the step down market, private pay and the development of non-residential forms of care.

Confirmed speakers include Marja Aarnio Isohanni, CEO, Esperi Care, one of the largest Finnish care providers, Fredrik Gren, CEO, Ambea, one of the two largest providers in Sweden, Philippe Tapié, CEO, Maisons de Famille Group which is active in France, Italy and Spain and French Alzheimer specialist Marc Saillon, managing director, Groupe Almage.

Changing the public/private debate Fredrik Gren, CEO, Ambea Ambea is one of the largest private players in the fast-evolving, highly-politicised Swedish care market. Its strategy has been to develop the expertise to manage those with complex needs, rather than simply going for the mass market. Here Fredrik looks at the dialogue Ambea has with payors and how this is changing. How do you prove quality and provide accurate comparisons between the private and public sectors? What are the prospects for the Swedish market?
Riding the Acquisition Tiger Marja Aarnio-Isohanni, CEO, Esperi Care Marja has built Esperi into one of the largest multi-faceted care groups in Finland with over 80 acquisitions and strong organic growth. Here she reflects on the lessons she has learnt moving from a not-for-profit to an organisation backed by private equity. What role can and should private equity play? And how will care in Finland develop over the next decade?
Opportunities in Elderly Care in Italy, Spain and France Philippe Tapié, CEO, Maisons de Famille Group MdeF is one of the French groups to expand across the continent. Here Philippe looks at prospects in Spain, Italy and France in elderly care. How doe these markets vary and how are they set to change over the next five to 10 years?
Meeting the challenge of Alzheimers Marc Saillon, Managing Director, Groupe Almage Almage is the largest residential specialist of Alzheimers in France with six homes around Paris, Reims and Bordeaux, and a 30 year track record of treatment. Marc looks at demand today and in the future for dementia care, before going on to look at common errors and what good care looks like.
Using Quality Outcomes to Build Brand and to Deepen Payor Relationships Yrjo Narhinen, CEO, Terveystalo Private operators need to demonstrate not just quality outcomes but also the full benefits of these for society in general. Yrjo looks at how Finnish group Terveystalo, the largest private operator in Europe in relation to country size, is building outcome feedback and using this data to influence payors, be they insurers, employers or government.
Building a B2C outpatient brand Johan Fredriksson, CEO, Praktikertjänst Praktikertjänst is the biggest mutual franchise of dentists and outpatient doctors in Europe with sales of over €1bn. Johan looks at how the organisation is building a B2C brand. What research has been conducted and how is Praktikertjänst winning the buy in of its proudly independent members?
Catalysts for Change Joseph Priel, serial healthcare services entrepreneur Joseph has an unmatched record in building successful healthcare service businesses across Central and Eastern Europe. His start-ups range from imaging services group Euromedic (now Affidea) through to the largest medtech distributor in the region. Today he has investments in operators in Hungary, Romania and Slovenia. Here he looks at how to make change happen and at how change will happen to the sector from central Europe to Russia. Hospital privatisation prospects in East Europe: A casestudy Martin Hrežo, CFO, Svet zdravia There have been waves of hospital privatisation in Poland, the Czech Rep and Slovakia. What are the prospects now? And what are the political challenges? Martin, CFO of the largest privatisation play in the region - Slovak group Svet zdravia with sales €150m - answers these questions and gives a casestudy of how privatisation works.
The Indian single speciality healthcare market - demand and growth Vikram Vora, CEO, Mydentist Vikram is CEO of the largest Indian dentistry group. Here he looks first at general trends in the Indian outpatient market. What do consumers look like, how do they think, how can you segment the market? He then focuses on the dentistry market and gives insights into MyDentist's business model.
Elderly care in Emerging Markets Bart Vanderschrick, CEO, Senior Assist International Senior Assist runs and owns over 50 care homes in Belgium, Chile, the Gulf and Uruguay and is planning reha, nursing and assisted living developments in Thailand, Turkey and Russia. This gives Bart a truly unique perspective! Here he looks at the different Emerging Markets and talks about the Senior Assist business model.
Care prospects and needs in the Middle East and North Africa Dr Helmut Schühsler, TVM Capital Healthcare TVM has made several investments in the care sector in the Gulf and has looked at the wider Middle East and North Africa region. Helmut looks at the opportunities for long-term care, homecare and elderly care, particularly in the Gulf. What is the landscape, the hurdles and the opportunities?
Elderly care in Brazil Marcelo Fonseca, CEO, Dalben Brazil is at the very start of the development of the elderly care market. Dalben is one of largest and most innovative private home and elderly care provider in Brazil today. Marcelo looks at current forms of elderly care and at how the Brazilian market will develop over the next decade.
How Gulf healthcare is set to change Ronald Lavater, CEO, Al Noor Hospital group Al Noor was at the centre of the largest healthcare services deal of 2015 and its new parent, Mediclinic, is set to join the London FTSE100. Ron, a former executive with HCA, the world's largest for-profit hospital chain, has spent the last seven years working in the sector in the Middle East, Here he looks at the Gulf and Middle Eastern healthcare services market today and how it is set to change. What are the innovations that will power growth over the next decade?
Hospital outsourcing - the Mexican model and beyond Jaime Cervantes, CEO, Vitalmex Public hospitals in Mexico routinely outsource a wide range of services and Vitalmex today has sales of $300m and works with 250 hospitals running everything from operating theatres to dialysis centres and procurement through to cardio-vascular programmes. The company has recently expanded into Colombia and Peru and plans to enter Turkey, Thailand and Brazil in 2016. Jaime looks at the Mexican public hospital sector and explains why he is so confident the model can be rolled out internationally.
The Chinese secondary care market Isabel Vaz, CEO, Luz Saude Fosun is one of the largest players in Chinese secondary care, as well as being an active investor in healthcare services wordwide. Here Isabel gives an overview of the Chinese hospital market and how it is changing. He then looks at Fosun's strategy for China and goes on to outline its international strategy.
Saudi Arabia - the creation of a new market Dr Ibrahim Al Omar, CEO, ACWA Healthcare Company Saudi Arabia Saudi Arabia has taken the radical decision to place almost the entire delivery of health services in the hands of the private sector and Dr Al Omar looks at the implications, challenges and opportunities thrown up by this change.

Dr Al Omar has recently stepped down as Deputy Minister in The Ministry of Health for laboratories and blood banks and now heads up a new operator backed by important investors. He was formerly general manager of the Dr Sulaiman Habib private hospital group.
Implementing Quality Dr Markus Hamm, Managing Director, Schoen Klinik How do you build quality indicators and use them to change culture and service delivery within an operator? Schoen Kliniken, Germany's fifth largest private hospital chain, has been pioneering quality for over two decades. Dr Hamm looks at what Schoen Klinik measures, how it uses the data to change behaviour and at how it is extending measurements to cover areas such as depression and eating disorders. What impact has this had on patients' perceptions?
Delivering Quality in Health and Care Dr. Stefan Larsson, Senior Partner and Managing Director, BCG Stockholm After years of health care management where payer focus has been on fee-for-service and cost per volume, the landscape is changing and the quality of services provided gaining in importance. Measurement of outcomes that matter to patients is increasingly demanded and when the data is made transparent it transforms the Health care landscape. Dr Larsson will share examples of where this is happening, describe the emergence of Global standards for outcomes measurement and the opportunities their adoption offers to progressive health care providers.
African lab markets Peter Cole, CEO, Lancet South African lab operator Lancet is building a Pan-African chain of labs and now has a physical presence in a dozen countries. Peter looks at how these markets differ, how they are changing and the challenges they present. He also looks at the broad thrust of healthcare development across Africa.
Opportunities in the Gulf and beyond Dr Sameh El Sheikh, CEO, Al Borg Medical Laboratories What does the Gulf lab market look like today and how is it set to change as countries roll out statutory insurance and turn increasingly to private sector providers. Al Borg has innovated by developing a powerful wellness platform. Sameh looks at how this has been rolled out and at opportunities beyond the Gulf Market.
Going Global Sanjeev Vashishta, CEO, SRL India's largest lab group is set to expand fast in Africa, the Middle East and CIS. Sanjeev first looks at the Indian market before going on to look at opportunities elsewhere. In particular he looks at how SRK integrates imaging into its business model.
This panel discussion will be kicked off by Thomas Pellerin who will set out what are likely to be the winning business models and at the main types of investors he sees emerging in the different regions.

Meeting the health needs of emerging consumers Michael Fernandes, Partner, LeapFrog Investments Billions of underserved emerging consumers across Africa and Asia are demanding access to essential services, including healthcare, to enable their rise into the middle class. Michael explores how to meet the burgeoning emerging consumer health need.

LeapFrog Investments is a specialist investor in emerging markets, seeking the growth opportunity presented by two billion emerging consumers in Africa and Asia. Using a profit-with-purpose approach, LeapFrog invests in companies providing essential financial tools and healthcare to emerging consumers earning below $10 a day. The former country head for India for Khazanah Nasional, Malaysia’s sovereign fund, Michael managed the healthcare portfolio, ranging from hospitals to health insurance providers, that was consolidated under IHH Healthcare and listed in Singapore for a $7 billion valuation.
Reducing costs in health care Farhad Riahi, Senior Partner, Richard Bartlett, Engagement Manager, McKinsey & Company and Dave Easton, Director and Head of Consumer Business, CDC Group As tariffs fall in Europe, so operators are looking to cut costs whilst increasing or maintaining quality. Farhad and Richard look at casestudies drawing particularly on players in Emerging Markets who are often delivering high quality at a fraction of the cost in Europe.
eHealh apps - the next step Alistair Wickens, CEO, Quealth Quealth is one of a few clinically-valid health apps successfully targeting the consumer health market in the UK, US and Australia. Alistair has extensive experience in creating a digital business which partners with some of the world’s largest technology companies around distribution and product development. In this session, he will unpack how an understanding of consumer behaviour and AI is helping to create longer-term engagement and influence health-related behaviour — particularly in relation to the health, insurance and retail markets.
Online booking and rating platforms - Opportunity or Threat? Marcin Szalek, COO, Docplanner The last five years has seen an exponential growth in rating/booking sites in health and care services. Docplanner, for instance, is now active across 25 countries in Africa, Asia and Europe, booking in hundreds of thousands of patients a month. Next steps for the sector are likely to see remote consultations. So are these platforms a threat to existing providers or are they potential partners who can help payors and operators to grow brands and coverage?
How integrated apps will change the world Ali Parsa, CEO and Founder, Babylon Health Launched in April 2015, the app offers diagnosis, consultations and medical record storage. The service works with the English NHS or as a subscription service. Ali looks at how such apps work today and how they will in the future. How will this change the way insurers and operators deliver services?
Saudi Arabia - the creation of a new market Dr Ibrahim Al Omar, CEO, ACWA Healthcare Company Saudi Arabia Saudi Arabia has taken the radical decision to place almost the entire delivery of health services in the hands of the private sector and Dr Al Omar looks at the implications, challenges and opportunities thrown up by this change.

Dr Al Omar has recently stepped down as Deputy Minister in The Ministry of Health for laboratories and blood banks and now heads up a new operator backed by important investors. He was formerly general manager of the Dr Sulaiman Habib private hospital group.
Sub-Saharan Africa - payors and governments Ian Clarke, Chairman of the East Africa Healthcare Federation Ian looks first at how governmental attitudes in Sub-Saharan Africa have changed. What impact will statutory healthcare insurance schemes and a new generation of PPPs have? He then looks at the payor landscape. Mhealth, micro insurance and catastrophic acute insurance are very fashionable today. But are they likely to provide a substantial reveue stream for providers? At the base of the pyramid Africa is likely to depend on NGOs - has their attitude towards for-profit providers changed?